Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction

Susanne W. M. van den Borne, Jack P. M. Cleutjens, Roeland Hanemaaijer, Esther E. Creemers, Jos F. M. Smits, Mat J. A. P. Daemen, W. Matthijs Blankesteijn

Research output: Contribution to journalArticleAcademicpeer-review

92 Citations (Scopus)

Abstract

Infarct rupture is a usually fatal complication of myocardial infarction (MI), for which no molecular mechanism has been described in humans. Experimental evidence in mouse models suggests that the degradation of the extracellular matrix by matrix metalloproteinases (MMPs) plays an important role in infarct rupture. The present study was designed to study the role of MMP-2, MMP-8, and MMP-9 in human infarct rupture. Heart samples were obtained from patients who died from infarct rupture and control MI patients. The MMP activity was determined by zymography and quantitative immunocapture activity assay. TIMP-1 levels were measured and immunohistochemistry for MMP-2 and MMP-9 was performed. The amounts of both total and active MMP-8 and MMP-9 were significantly higher in ruptured infarct tissue than in control MI tissue, but no differences in MMP-2 activity were observed. Furthermore, the number of inflammatory cells was significantly higher in the ruptured infarcts than in control infarcts. These data suggest that increased MMP-8 and MMP-9 activity in the infarct area, caused by a more prominent infiltration of inflammatory cells, contribute to infarct rupture in humans
Original languageEnglish
Pages (from-to)37-43
JournalCardiovascular pathology
Volume18
Issue number1
DOIs
Publication statusPublished - 2009

Cite this